📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Meritage Pharma

1.1 - Company Overview

Meritage Pharma Logo

Meritage Pharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of prescription products for gastrointestinal and atopic diseases, offering budesonide-based therapies, including an oral budesonide suspension and budesonide API used in treatments for pediatric asthma, allergic rhinitis, and Crohn's disease.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Meritage Pharma

Finch Therapeutics Logo

Finch Therapeutics

HQ: United States Website
  • Description: Provider of microbiome development services focused on serving patients with serious unmet medical needs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Finch Therapeutics company profile →
Palisade Bio Logo

Palisade Bio

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical therapies for acute and chronic gastrointestinal complications, including PALI-2108, a microbiota-activated PDE4 inhibitor prodrug for moderate-to-severe ulcerative colitis, and PALI-1908, a preclinical prodrug for fibro stenotic Crohn’s Disease; supported by a Precision Delivery Platform that uses the phosphodiesterase-4 (PDE4) enzyme as its first therapeutic target to deliver drugs locally in the GI tract, minimizing systemic exposure.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Palisade Bio company profile →
CinDome Pharma Logo

CinDome Pharma

HQ: United States Website
  • Description: Provider of treatment for the millions of people living with the devastating impact of chronic gastroparesis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CinDome Pharma company profile →
Innovate Biopharma Logo

Innovate Biopharma

HQ: United States Website
  • Description: Provider of clinical-stage biotechnology drug candidates for gastroenterological and orphan disorders: INN-202 (Phase 3, celiac disease), INN-329 (Phase 3, enhances pancreatic duct visualization in MRCP diagnostics), INN-108 (Phase 2, mild to moderate ulcerative colitis and other inflammatory bowel disorders), INN-217 (Phase 1/2, nonalcoholic steatohepatitis), and INN-289 (Phase 1, subset of Crohn’s disease).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Innovate Biopharma company profile →
CinRx Logo

CinRx

HQ: United States Website
  • Description: Provider of therapies for unmet needs, advancing new molecular entities via partnerships and expertise. Pipeline includes obesity treatments such as CIN-110 (PYY3-36 analog), CIN-109 (GDF-15 analog), and CIN-209 (GLP-1/GDF-15 dual agonist); TTP399, an oral glucokinase activator adjunct to insulin for type 1 diabetes; CIN-102, a D2/D3 antagonist for gastroparesis; CIN-103, phloroglucinol for IBS-D.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CinRx company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Meritage Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Meritage Pharma

2.2 - Growth funds investing in similar companies to Meritage Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Meritage Pharma

4.2 - Public trading comparable groups for Meritage Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Meritage Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Meritage Pharma

What does Meritage Pharma do?

Meritage Pharma is a provider of prescription products for gastrointestinal and atopic diseases, offering budesonide-based therapies, including an oral budesonide suspension and budesonide API used in treatments for pediatric asthma, allergic rhinitis, and Crohn's disease.

Who are Meritage Pharma's competitors?

Meritage Pharma's competitors and similar companies include Finch Therapeutics, Palisade Bio, CinDome Pharma, Innovate Biopharma, and CinRx.

Where is Meritage Pharma headquartered?

Meritage Pharma is headquartered in United States.

How many employees does Meritage Pharma have?

Meritage Pharma has 1,000 employees 🔒.

When was Meritage Pharma founded?

Meritage Pharma was founded in 2010 🔒.

What sector and industry vertical is Meritage Pharma in?

Meritage Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Meritage Pharma

Who are the top strategic acquirers in Meritage Pharma's sector and industry

Top strategic M&A buyers and acquirers in Meritage Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Meritage Pharma?

Top strategic M&A buyers groups and sectors for Meritage Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Meritage Pharma's sector and industry vertical

Which are the top PE firms investing in Meritage Pharma's sector and industry vertical?

Top PE firms investing in Meritage Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Meritage Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Meritage Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Meritage Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Meritage Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Meritage Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Meritage Pharma?

The key public trading comparables and valuation benchmarks for Meritage Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Meritage Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Meritage Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Meritage Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Meritage Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Meritage Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Meritage Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Meritage Pharma